Literature DB >> 11239748

Opioid poorly-responsive cancer pain. Part 2: basic mechanisms that could shift dose response for analgesia.

S Mercadante1, R K Portenoy.   

Abstract

Basic research in experimental pain models may illuminate the phenomenon of cancer pain that is poorly responsive to opioid drugs. Research findings can be valuable in formulating new strategies in clinical practice. This review evaluated experimental observations in terms of the events that occur in cancer patients receiving opioid therapy for pain.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11239748     DOI： 10.1016/s0885-3924(00)00236-0

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


  10 in total

1.  A Practical Approach to Acute Postoperative Pain Management in Chronic Pain Patients.

Authors:  Edwin N Aroke; Susan P McMullan; Katie O Woodfin; Ryan Richey; Jordan Doss; Bryan A Wilbanks
Journal:  J Perianesth Nurs       Date:  2020-07-11       Impact factor: 1.084

Review 2.  The switch from buprenorphine to tapentadol: is it worth?

Authors:  Adriana Miclescu
Journal:  Rom J Anaesth Intensive Care       Date:  2016-10

3.  Opioid-Induced Tolerance and Hyperalgesia.

Authors:  Sebastiano Mercadante; Edoardo Arcuri; Angela Santoni
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

4.  Palliative embolisation for advanced bone sarcomas.

Authors:  A F Mavrogenis; G Rossi; G Altimari; T Calabrò; A Angelini; E Palmerini; E Rimondi; P Ruggieri
Journal:  Radiol Med       Date:  2012-08-09       Impact factor: 3.469

Review 5.  Management of pain in the elderly at the end of life.

Authors:  Eric Prommer; Brandy Ficek
Journal:  Drugs Aging       Date:  2012-04-01       Impact factor: 3.923

6.  The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study.

Authors:  Sebastiano Mercadante; Patrizia Ferrera; Edoardo Arcuri
Journal:  Support Care Cancer       Date:  2010-09-30       Impact factor: 3.603

7.  Addition of a second opioid may improve opioid response in cancer pain: preliminary data.

Authors:  Sebastiano Mercadante; Patrizia Villari; Patrizia Ferrera; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

8.  Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer.

Authors:  Tamara King; Anna Vardanyan; Lisa Majuta; Ohannes Melemedjian; Ray Nagle; Anne E Cress; Todd W Vanderah; Josephine Lai; Frank Porreca
Journal:  Pain       Date:  2007-08-15       Impact factor: 6.961

9.  The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.

Authors:  Shelley R Salpeter; Jacob S Buckley; Eduardo Bruera
Journal:  J Palliat Med       Date:  2013-04-04       Impact factor: 2.947

10.  Opioid-induced hyperalgesia: when pain killers make pain worse.

Authors:  Anshuni Kaneria
Journal:  BMJ Case Rep       Date:  2014-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.